133 related articles for article (PubMed ID: 9096662)
1. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients.
Okita M; Gaudette DC; Mills GB; Holub BJ
Int J Cancer; 1997 Mar; 71(1):31-4. PubMed ID: 9096662
[TBL] [Abstract][Full Text] [Related]
2. The significance of plasma lysophospholipids in patients with renal failure on hemodialysis.
Sasagawa T; Suzuki K; Shiota T; Kondo T; Okita M
J Nutr Sci Vitaminol (Tokyo); 1998 Dec; 44(6):809-18. PubMed ID: 10197312
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment.
Conquer JA; Tierney MC; Zecevic J; Bettger WJ; Fisher RH
Lipids; 2000 Dec; 35(12):1305-12. PubMed ID: 11201991
[TBL] [Abstract][Full Text] [Related]
4. Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis.
Paapstel K; Kals J; Eha J; Tootsi K; Ottas A; Piir A; Jakobson M; Lieberg J; Zilmer M
Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):44-52. PubMed ID: 28986077
[TBL] [Abstract][Full Text] [Related]
5. Linoleoyl lysophosphatidylcholine is an efficient substrate for soybean lipoxygenase-1.
Huang LS; Kim MR; Sok DE
Arch Biochem Biophys; 2006 Nov; 455(2):119-26. PubMed ID: 17067544
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.
Klouwer FCC; Ferdinandusse S; van Lenthe H; Kulik W; Wanders RJA; Poll-The BT; Waterham HR; Vaz FM
J Inherit Metab Dis; 2017 Nov; 40(6):875-881. PubMed ID: 28677031
[TBL] [Abstract][Full Text] [Related]
7. Plasma 1-palmitoyl-2-linoleoyl phosphatidylcholine. Evidence for extensive phospholipase A1 hydrolysis and hepatic metabolism of the products.
Scagnelli GP; Cooper PS; VandenBroek JM; Berman WF; Schwartz CC
J Biol Chem; 1991 Sep; 266(27):18002-11. PubMed ID: 1917938
[TBL] [Abstract][Full Text] [Related]
8. Quantitative studies on translocation and metabolic conversion of lysophosphatidylcholine incorporated into the membrane of intact human erythrocytes from the medium.
Tamura A; Tanaka T; Yamane T; Nasu R; Fujii T
J Biochem; 1985 Jan; 97(1):353-9. PubMed ID: 3997795
[TBL] [Abstract][Full Text] [Related]
9. Shape change of human erythrocytes induced by phosphatidylcholine and lysophosphatidylcholine species with various acyl chain lengths.
Fujii T; Tamura A
Cell Biochem Funct; 1984 Jul; 2(3):171-6. PubMed ID: 6478541
[TBL] [Abstract][Full Text] [Related]
10. Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.
Yin MZ; Tan S; Li X; Hou Y; Cao G; Li K; Kou J; Lou G
Tumour Biol; 2016 Apr; 37(4):5485-92. PubMed ID: 26566624
[TBL] [Abstract][Full Text] [Related]
11. Disappearance of two major phosphatidylcholines from plasma is predominantly via LCAT and hepatic lipase.
Shamburek RD; Zech LA; Cooper PS; Vandenbroek JM; Schwartz CC
Am J Physiol; 1996 Dec; 271(6 Pt 1):E1073-82. PubMed ID: 8997228
[TBL] [Abstract][Full Text] [Related]
12. Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases.
Raynor A; Jantscheff P; Ross T; Schlesinger M; Wilde M; Haasis S; Dreckmann T; Bendas G; Massing U
Lipids Health Dis; 2015 Jul; 14():69. PubMed ID: 26162894
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylcholine metabolism for energy production in sea urchin spermatozoa.
Mita M; Ueta N
Biochim Biophys Acta; 1990 Nov; 1047(2):175-9. PubMed ID: 2248974
[TBL] [Abstract][Full Text] [Related]
14. Formation and characterization of phosphatidylethanolamine/lysophosphatidylcholine mixed vesicles.
Sun C; Hanasaka A; Kashiwagi H; Ueno M
Biochim Biophys Acta; 2000 Jul; 1467(1):18-26. PubMed ID: 10930505
[TBL] [Abstract][Full Text] [Related]
15. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
[TBL] [Abstract][Full Text] [Related]
16. Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.
Zeleznik OA; Clish CB; Kraft P; Avila-Pacheco J; Eliassen AH; Tworoger SS
J Natl Cancer Inst; 2020 Jun; 112(6):628-636. PubMed ID: 31593240
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidylcholine stabilizes small unilamellar phosphatidylcholine vesicles. Phosphorus-31 NMR evidence for the "wedge" effect.
Kumar VV; Malewicz B; Baumann WJ
Biophys J; 1989 Apr; 55(4):789-92. PubMed ID: 2720071
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylcholine inhibits and lysophosphatidylcholine enhances the lymphatic absorption of alpha-tocopherol in adult rats.
Koo SI; Noh SK
J Nutr; 2001 Mar; 131(3):717-22. PubMed ID: 11238749
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidylcholine increases apolipoprotein B secretion by enhancing lipid synthesis and decreasing its intracellular degradation in HepG2 cells.
Zhou Z; Luchoomun J; Bakillah A; Hussain MM
Biochim Biophys Acta; 1998 Mar; 1391(1):13-24. PubMed ID: 9518534
[TBL] [Abstract][Full Text] [Related]
20. Analysis of phosphatidylcholine oxidation products in human plasma using quadrupole time-of-flight mass spectrometry.
Adachi J; Asano M; Yoshioka N; Nushida H; Ueno Y
Kobe J Med Sci; 2006; 52(5):127-40. PubMed ID: 17006053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
